XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Nov. 30, 2025
May 31, 2025
Current assets    
Cash and cash equivalents $ 1,956,030 $ 1,190,656
Short-term investments 38,787,922 34,799,367
Accounts receivable, net 5,180,955 5,599,785
Inventory 7,867,303 8,113,321
Costs and estimated earnings in excess of billings 2,424,165 5,360,499
Other current assets 1,712,737 1,219,211
Total current assets 57,929,112 56,282,839
Maintenance and other inventory, net 1,162,840 1,107,875
Property and equipment, net 12,659,629 12,074,172
Patents, net 259,258 270,370
Other assets 287,279 284,864
Deferred income taxes 546,000 1,598,000
Assets 72,844,118 71,618,120
Current liabilities    
Accounts payable 1,616,645 1,119,240
Accrued expenses 2,544,802 4,072,436
Billings in excess of costs and estimated earnings 1,621,647 4,382,067
Total current liabilities 5,783,094 9,573,743
Stockholders' equity    
Common stock and additional paid-in capital 15,531,385 14,649,415
Retained earnings 64,738,862 60,540,154
Treasury stock - at cost (13,209,223) (13,145,192)
Total stockholders' equity 67,061,024 62,044,377
Liabilities and Equity $ 72,844,118 $ 71,618,120